Taipei, Taiwan In 1924 was created YFY Inc., which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in Taiwan. The main office of represented Corporate Investor is situated in the Taipei.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the YFY Inc., startups are often financed by Trillium Group, Shin Kong Life Insurance, Major Series A. The meaningful sponsors for the fund in investment in the same round are MPM Capital, YFY Biotech Management Company, Trillium Group. In the next rounds fund is usually obtained by YFY Biotech Management Company, Taiwan Sugar Corporation, National Development Fund of Taiwan Government.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight TaiGen Biotechnology, Omni-ID. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Logistics, Software.
The important activity for fund was in 2016. The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Diagnostic Systems Laboratories | Texas, United States, Webster |
| EnerDel | New York, New York, United States |
| ESPN | Bristol, Connecticut, United States |
| Finparx | Berlin, Berlin, Germany |
| Gaydoul Group | Pfaffikon, Switzerland, Zurich |
| Hangzhou Jinrong Touzi | China, Hangzhou, Zhejiang |
| Japan-Portal | - |
| MGV Capital Group | San Antonio, Texas, United States |
| NEXEA Venture Capital & Angel Investors | Kuala Lumpur, Malaysia |
| Parish Capital Advisors | Chapel Hill, North Carolina, United States |
| PPM America Capital Partners | Chicago, Illinois, United States |
| Rising Dragon Singapore Pte Ltd | Central, Central Region, Singapore |
| Safeco Insurance | Boston, Massachusetts, United States |
| Stonepeak Infrastructure Partners | New York, New York, United States |
| Tenth Avenue Holdings | New York, New York, United States |
| UniCredit Start Lab FinTech Accelerator | Italy, Lombardy, Milan |
| Universities Superannuation Scheme | England, Liverpool, United Kingdom |
| Zijinhui | Beijing, China, Haidian |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
TaiGen Biotechnology | $37M | 01 Jan 2009 | New Taipei, Taiwan | ||
TaiGen Biotechnology | $38M | 16 Mar 2004 | New Taipei, Taiwan |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
TaiGen Biotechnology | $37M | 01 Jan 2009 | New Taipei, Taiwan | ||
TaiGen Biotechnology | $38M | 16 Mar 2004 | New Taipei, Taiwan |
